-
IV-23
- names:
IV-23
- CAS号:
2326007-49-0
MDL Number: - MF(分子式): C18H18BrNO4 MW(分子量): 392.24
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM001494-250mg | 250mg | ¥ 0.00 | ¥ 0.00 | Backorder | ¥ 0.00 | |||
| YZM001494-100mg | 100mg | >97% | ¥ 0.00 | ¥ 0.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | IV-23 |
| CAS号 | 2326007-49-0 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C18H18BrNO4 |
| 分子量 Molecular Weight | 392.24 |
| 溶解度Solubility | |
| 性状 | |
| 储藏条件 Storage conditions | 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description. |
| 产品说明 | |
| Introduction | IV3 (Compound 20) is a potent Noxa mediatedapoptosisinducer, and it is a promising anticancer agent with potential. IV3 inhibits cell growths in vitro and in vivo, reduces colony formation, arrests cell cycle at M phase, and induces esophageal squamous cell carcinoma (ESCC). |
| Application1 | |
| Application2 | |
| Application3 |
IV-23 (Compound 20) 是一种有效的 Noxa 介导的细胞凋亡诱导剂,它是一种有效的有潜力的有前景的抗癌剂。IV-23 在体外和体内抑制细胞生长,减少集落形成,在 M 期停滞细胞周期,并抑制食管鳞状细胞癌 (ESCC)。IV-23 (Compound 20) is a potent Noxa mediatedapoptosisinducer, and it is a promising anticancer agent with potential. IV-23 inhibits cell growths in vitro and in vivo, reduces colony formation, arrests cell cycle at M phase, and induces esophageal squamous cell carcinoma (ESCC)[1].
【1】.Fu DJ, et al. Discovery of indoline derivatives that inhibit esophageal squamous cell carcinoma growth by Noxa mediated apoptosis. Bioorg Chem. 2019 Aug 10;92:103190.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


